Mass General Brigham, Inc Portfolio Holdings

Mass General Brigham, Inc

  • $43.6 Billion
  • Q3 2024

Mass General Brigham, Inc has filed its 13F form on October 16, 2024 for Q3 2024 where it was disclosed a total value porftolio of $43.6 Billion distributed in 50 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Samsara Inc. with a value of $21.6B, Revolution Medicines, Inc. with a value of $15.3B, Pliant Therapeutics, Inc. with a value of $3.24B, Tango Therapeutics, Inc. with a value of $2.73B, and Fulcrum Therapeutics, Inc. with a value of $733M.

Examining the 13F form we can see an increase of $23.1B in the current position value, from $20.5B to 43.6B.

Below you can find more details about Mass General Brigham, Inc portfolio as well as his latest detailed transactions.

Portfolio value $43.6 Billion
Healthcare: $22 Billion
Technology: $21.6 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$158M
$733 Million 1.68% of portfolio
205,356
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 50
  • Current Value $43.6 Billion
  • Prior Value $20.5 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 16, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Mass General Brigham, Inc Portfolio

Follow Mass General Brigham, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mass General Brigham, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mass General Brigham, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email